More News

05 Apr 2018 Novo Nordisk obtains exclusive worldwide licence to EpiDestiny's sickle cell disease programme
05 Apr 2018 Terns Pharmaceuticals Acquires Global, Exclusive Rights to Develop and Commercialize Three NASH Assets from Lilly
05 Apr 2018 Arsanis Out-Licenses Preclinical Stage E. coli Monoclonal Antibodies
05 Apr 2018 PTC Therapeutics and CHDI Foundation Announce a Collaboration on a Small-Molecule Therapeutic for Huntington's Disease
05 Apr 2018 Boehringer Ingelheim and OSE Immunotherapeutics Announce Global Immuno-Oncology Partnership to Develop a Pioneering Checkpoint Inhibitor for the Treatment of Advanced Solid Tumors
05 Apr 2018 Kymera Therapeutics Announces Discovery Collaboration with GSK to Advance New Treatment Modality
05 Apr 2018 Daiichi Sankyo and DarwinHealth Enter Exclusive Research Collaboration for Novel Cancer Target Initiative
05 Apr 2018 UCB strengthens research capabilities with acquisition of Element Genomics, a Duke University biotech spin-off
05 Apr 2018 Takeda Pharmaceutical and DNDi Collaborate to Progress a Potential New Drug for Visceral Leishmaniasis through the R&D Pipeline
05 Apr 2018 Lilly and Sigilon Therapeutics Announce Strategic Collaboration to Develop Encapsulated Cell Therapies for the Treatment of Type 1 Diabetes
04 Apr 2018 IONTAS and IGEM Therapeutics Collaborate to Identify Novel IgE Antibodies for Cancer Targets
03 Apr 2018 Pfizer and Allogene Therapeutics Enter into Asset Contribution Agreement for Pfizer’s Allogeneic CAR T Immuno-oncology Portfolio
02 Apr 2018 Compugen Announces Exclusive License Agreement With MedImmune for the Development of Bi-Specific and Multi-Specific Antibody Products
02 Apr 2018 XBiotech In-licenses Anti-NY-ESO-1 Antibody Targeting Advanced Cancer
29 Mar 2018 Indivior Enters Into an Exclusive Global License Agreement for C4X Discovery's Orexin-1 (OX1) Antagonist Program
28 Mar 2018 Actinium Pharmaceuticals Announces Collaborative Research Partnership with Astellas Leveraging Actinium’s AWE Platform Technology
28 Mar 2018 bluebird bio and Celgene Corporation Enter into Agreement to Co-Develop and Co-Promote Anti-BCMA CAR T Cell Therapy bb2121 in the United States
28 Mar 2018 Abide and Celgene Enter Worldwide License Agreement for ABX-1772
28 Mar 2018 Eisai and Nichi-Iko Pharmaceutical enter into strategic alliance agreement
26 Mar 2018 Shire and NanoMedSyn Enter Into Research Agreement for Potential Lysosomal Storage Disorder Treatment
22 Mar 2018 CBT Pharmaceuticals to Grow Immuno-Oncology Pipeline by License Agreement of CrownBio CTLA-4 Antibody
22 Mar 2018 Innate Biologics, LLC Enters Into Collaboration Agreement With The Wistar Institute to Develop Anti-Inflammatory Protein Platform
22 Mar 2018 Regeneron and Alnylam Pharmaceuticals Announce Collaboration to Discover New Treatments for Nonalcoholic Steatohepatitis (NASH)
22 Mar 2018 Helix BioPharma Corp. Signs Collaboration Agreement With ProMab Biotechnologies to Co-Develop CAR-T for Hematological Malignancies
21 Mar 2018 Prothena Announces Global Neuroscience Research & Development Collaboration with Celgene for Novel Therapies for Patients with Neurodegenerative Diseases

La Merie Biologics

FREE Weekly News Bulletin

Sign Up

2017 Sales ofAntibodies & Proteins

New Product Alert

For La Merie Publishing

Sign Up